118 related articles for article (PubMed ID: 12192307)
1. Successful thyroidectomy in a patient with Hermansky-Pudlak syndrome treated with recombinant activated factor VII and platelet concentrates.
del Pozo Pozo AI; Jiménez-Yuste V; Villar A; Quintana M; Hernández-Navarro F
Blood Coagul Fibrinolysis; 2002 Sep; 13(6):551-3. PubMed ID: 12192307
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
Ozelo MC; Svirin P; Larina L
Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
[TBL] [Abstract][Full Text] [Related]
4. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
[TBL] [Abstract][Full Text] [Related]
5. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
[TBL] [Abstract][Full Text] [Related]
6. Variable response of Hermansky-Pudlak syndrome to prophylactic administration of 1-desamino 8D-arginine in subsequent pregnancies.
Zatik J; Póka R; Borsos A; Pfliegler G
Eur J Obstet Gynecol Reprod Biol; 2002 Sep; 104(2):165-6. PubMed ID: 12206932
[TBL] [Abstract][Full Text] [Related]
7. Therapy refractory menorrhagia as first manifestation of Hermansky-Pudlak syndrome.
Lohse J; Gehrisch S; Tauer JT; Knöfler R
Hamostaseologie; 2011 Nov; 31 Suppl 1():S61-3. PubMed ID: 22057877
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.
Yilmaz AA; Yalcin S; Serdaroglu H; Sonmezer M; Uysalel A
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):693-5. PubMed ID: 18832912
[TBL] [Abstract][Full Text] [Related]
9. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery].
Gong ZY; Gao CQ; Xiao CS; Li BJ; Ma XH; Zhang CM
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1497-501. PubMed ID: 19094631
[TBL] [Abstract][Full Text] [Related]
10. A novel two-nucleotide deletion in HPS6 affects mepacrine uptake and platelet dense granule secretion in a family with Hermansky-Pudlak syndrome.
Andres O; Wiegering V; König EM; Schneider AL; Semeniak D; Stritt S; Klopocki E; Schulze H
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27917594
[TBL] [Abstract][Full Text] [Related]
11. Surgery in patients with congenital factor VII deficiency - a single center study.
Szczepanik A; Wiszniewski A; Oses-Szczepanik A; Dąbrowski W; Pielaciński K; Misiak A
Pol Przegl Chir; 2018 May; 90(5):1-5. PubMed ID: 30426948
[TBL] [Abstract][Full Text] [Related]
12. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
Levy-Mendelovich S; Levy T; Budnik I; Barg AA; Rosenberg N; Seligsohn U; Kenet G; Livnat T
Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
[TBL] [Abstract][Full Text] [Related]
13. DNA diagnosis and management of Hermansky-Pudlak syndrome in pregnancy.
Wax JR; Rosengren S; Spector E; Gainey AJ; Ingardia CJ
Am J Perinatol; 2001 May; 18(3):159-61. PubMed ID: 11414528
[TBL] [Abstract][Full Text] [Related]
14. Hermansky-Pudlak syndrome: Report of two patients with updated genetic classification and management recommendations.
Loredana Asztalos M; Schafernak KT; Gray J; Berry A; Paller AS; Mancini AJ
Pediatr Dermatol; 2017 Nov; 34(6):638-646. PubMed ID: 29044644
[TBL] [Abstract][Full Text] [Related]
15. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial.
Sachs B; Delacy D; Green J; Graham RS; Ramsay J; Kreisler N; Kruse P; Khutoryansky N; Hu SS
Spine (Phila Pa 1976); 2007 Oct; 32(21):2285-93. PubMed ID: 17906567
[TBL] [Abstract][Full Text] [Related]
19. Infantile-onset inflammatory bowel disease in a patient with Hermansky-Pudlak syndrome: a case report.
Ishihara J; Mizuochi T; Uchida T; Takaki Y; Konishi KI; Joo M; Takahashi Y; Yoshioka S; Kusano H; Sasahara Y; Yamashita Y
BMC Gastroenterol; 2019 Jan; 19(1):9. PubMed ID: 30634918
[TBL] [Abstract][Full Text] [Related]
20. Hermansky-Pudlak syndrome.
Krisp A; Hoffman R; Happle R; König A; Freyschmidt-Paul P
Eur J Dermatol; 2001; 11(4):372-3. PubMed ID: 11399548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
